SC-50410

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameSC-50410

Drug Alias NameSC-50410

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSerotonin 4 (5-HT4) receptor agonistsSerotonin 3 (5-HT3) receptor antagonists

TargetsSerotonin 4 (5-HT4) receptorSerotonin 3 (5-HT3) receptor

Therapy Area/IndicationsGastrointestinal motility disorders

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsGastrointestinal motility disorders

ATC CodeN/A